Диссертация (1140944), страница 18
Текст из файла (страница 18)
2012 Jun;134(3):30616. doi: 10.1016/j.pharmthera.2012.02.00368 Gray S, Kim JK. / New insights into insulin resistance in the diabetic heart //TrendsEndocrinolMetab.2011Oct;22(10):394-403.doi:10.1016/j.tem.2011.05.00169 Ha JW, Lee HC, Kang ES, Ahn CM, Kim JM, Ahn JA, et al. / Abnormal leftventricular longitudinal functional reserve in patients with diabetes mellitus:implication for detecting subclinical myocardial dysfunction using exercise tissueDopplerechocardiography//Heart2007;93(12):1571–6.doi:10.1136/hrt.2006.10166770 Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M.
/ Mortality fromcoronary heart disease in subjects with type 2 diabetes and in nondiabetic subjectswith and without prior myocardial infarction // N Engl J Med. 1998 Jul23;339(4):229-34. doi: 10.1056/NEJM19980723339040471 Halliwell B, Gutteridge CMJ. / Free Radicals in Biology and Medicine // OxfordUniversity Press; Oxford: 1999.72 Hayat SA, Patel B, Khattar RS, Malik RA. / Diabetic cardiomyopathy:mechanisms, diagnosis and treatment // Clin Sci (Lond). 2004 Dec;107(6):539-57.doi: 10.1042/CS2004005773 Holvoet P, Harris TB, Tracy RP, et al.
/ Association of high coronary heart diseaserisk status with circulating oxidized LDL in the well-functioning elderly: findings125from the Health, Aging, and Body Composition study // Arterioscler Thromb VascBiol. 2003 Aug 1;23(8):1444-8. doi: 10.1161/01.ATV.0000080379.05071.2274 Holvoet P, Jenny NS, Schreiner PJ, Tracy RP, Jacobs DR. / The relationshipbetween oxidized LDL and other cardiovascular risk factors and subclinical CVDin different ethnic groups: The Multi-Ethnic Study of Atherosclerosis //(MESA) Atherosclerosis.2007Sep;194(1):245-52.doi:10.1016/j.atherosclerosis.2006.08.00275 Holvoet P, Kritchevsky SB, Tracy RP, et al.
/ The metabolic syndrome, circulatingoxidized LDL, and risk of myocardial infarction in well-functioning elderly peoplein the health, aging, and body compositioncohort// Diabetes. 2004Apr;53(4):1068-73.76 Holvoet P, Mertens A, Verhamme P, et al. / Circulating oxidized LDL is a usefulmarker for identifying patients with coronary artery disease // Arterioscler ThrombVasc Biol. 2001 May;21(5):844-8.77 Honjo M, Nakamura K, Yamashiro K, et al. / Lectin-like oxidized LDL receptor-1is a cell-adhesion molecule involved in endotoxin-induced inflammation // ProcNatl Acad Sci U S A.
2003 Feb 4;100(3):1274-9. doi: 10.1073/pnas.033752810078 Hoogeveen RC, Ballantyne CM, Bang H, et al. / Circulating oxidised low-densitylipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetesmellitus: the Atherosclerosis Risk in Communities Study // Diabetologia. 2007Jan;50(1):36-42.79 Hoyt RH, Collins SM, Skorton DJ, Ericksen EE, Conyers D. / Assessment offibrosis in infarcted human hearts by analysis of ultrasonic backscatter //Circulation. 1985 Apr;71(4):740-4.80 Hsueh W, Abel ED, Breslow JL, Maeda N, Davis RC, Fisher EA, et al.
/ Recipesfor creating animal models of diabetic cardiovascular disease // Circ Res2007;100(10):1415–27. doi: 10.1161/01.RES.0000266449.37396.1f81 Hu C, Dandapat A, Sun L, et al. / Regulation of TGFbeta1-mediated collagenformation by LOX-1: studies based on forced overexpression of TGFbeta1 in wild-126type and lox-1 knock-out mouse cardiac fibroblasts // J Biol Chem. 2008 Apr18;283(16):10226-31. doi: 10.1074/jbc.M70882020082 Hulthe J, Fagerberg B. / Circulating oxidized LDL is associated with subclinicalatherosclerosisdevelopmentandinflammatorycytokines(AIRStudy)// Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1162-7.83 Iribarren C, Karter AJ, Go AS et al. / Glycemic control and heart failure amongadult patients with diabetes // Circulation. 2001 Jun 5;103(22):2668-73.84 Islam KN, Takahashi M, Higashiyama S, Myint T, Uozumi N. / Fragmentation ofceruloplasmin following non-enzymatic glycation reaction // J Biochem.
1995Nov;118(5):1054-60.85 Janeway CA Jr, Travers P, Walport M, Shlomchik M. / Immunobiology: TheImmune System in Health and Disease. 6th Edition // New York: GarlandPublishing, 2005.86 Kang BY, Mehta JL. / Rosuvastatin attenuates Ang II—mediated cardiomyocytehypertrophy via inhibition of LOX-1 // J Cardiovasc Pharmacol Ther. 2009Dec;14(4):283-91. doi: 10.1177/107424840934432987 Kannel WB, McGee DL.
/ Diabetes and Cardiovascular Disease. The FraminghamStudy//JAMA.1979;241(19):2035–2038.doi:10.1001/jama.1979.0329045003302088 Karadeniz G, Acikgoz S, Tekin IO, et al. / Oxidized Low-Density-LipoproteinAccumulation is Associated with Liver Fibrosis in Experimental Cholestasis //Clinics(SaoPaulo).2008Aug;63(4):531-40.doi:10.1590/S1807-5932200800040002089 Kataoka H, Kume N, Miyamoto S, et al. / Expression of lectinlike oxidized lowdensity lipoprotein receptor-1 in human atherosclerotic lesions // Circulation.
1999Jun 22;99(24):3110-7.90 Khatter JC, Sadri P, Zhang M, Hoeschen RJ. / Myocardial angiotensin II (Ang II)receptors in diabetic rats // Ann N Y Acad Sci. 1996 Sep 30;793:466-72.12791 King DE, Mainous AG 3rd, Buchanan TA, Pearson WS. / C-reactive protein andglycemic control in adults with diabetes // Diabetes Care. 2003 May;26(5):1535-9.doi: 10.2337/diacare.26.5.153592 Klappacher G, Franzen P, Haab D, et al. / Measuring extracellular matrix turnoverin the serum of patients with idiopathic or ischemic dilated cardiomyopathy andimpact on diagnosis and prognosis // The American Journal of Cardiology.1995;75:913-918.
doi:10.1016/s0002-9149(99)80686-993 Konno T, Nagata Y, Teramoto R, et al. / Usefulness of ElectrocardiographicVoltage to Determine Myocardial Fibrosis in Hypertrophic Cardiomyopathy // AmJ Cardiol. 2016 Feb 1;117(3):443-9. doi: 10.1016/j.amjcard.2015.11.01594 Krahenbuhl S, Talos C, Fischer S, Reichen J. / Toxicity of bile acids on the electrontransportchainofisolatedratlivermitochondria// Hepatology.1994Feb;19(2):471-9.95 Kume N1, Murase T, Moriwaki H, et al.
/ Inducible expression of lectin-likeoxidized LDL receptor-1 in vascular endothelial cells // Circ Res. 1998 Aug10;83(3):322-7.96 Lang RM, Bierig M, Devereux RB, et al. / Recommendations for chamberquantification: a report from the American Society of Echocardiography'sGuidelines and Standards Committee and the Chamber Quantification WritingGroup,developedinconjunctionwiththeEuropeanAssociationofEchocardiography, a branch of the European Society of Cardiology // J Am SocEchocardiogr.
2005 Dec;18(12):1440-63. doi: 10.1016/j.echo.2005.10.00597 Lau DC, Shen GX. / Cardiovascular complications of diabetes // Can J Diabetes.2013 Oct;37(5):279-81. doi: 10.1016/j.jcjd.2013.08.26198 Lebeche D, Davidoff AJ, Hajjar RJ. / Interplay between impaired calciumregulation and insulin signaling abnormalities in diabetic cardiomyopathy // NatClin Pract Cardiovasc Med.
2008 Nov;5(11):715-24. doi: 10.1038/ncpcardio134712899 Leem J, Koh EH. / Interaction between mitochondria and the endoplasmicreticulum: implications for the pathogenesis of type 2 diabetes mellitus // ExpDiabetes Res. 2012;2012:242984. doi: 10.1155/2012/242984100 Leiva E., Wehinger S., Guzmán L., Orrego R. / Role of Oxidized LDL inAtherosclerosis, Hypercholesterolemia, Dr. Sekar Ashok Kumar Edition // London:InTech;2015.DOI:10.5772/59375.Availablefrom:https://www.intechopen.com/books/hypercholesterolemia/role-of-oxidized-ldl-inatherosclerosis101 Li D, Mehta JL. / Antisense to LOX-1 inhibits oxidized LDL-mediatedupregulation of monocyte chemoattractant protein-1 and monocyte adhesion tohuman coronary artery endothelial cells // Circulation. 2000 Jun 27;101(25):288995.
doi: 10.1161/01.CIR.101.25.2889102 Li D, Patel AR, Klibanov AL, et al. / Molecular imaging of atherosclerotic plaquestargeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance //CircCardiovascImaging.2010Jul;3(4):464-72.doi:10.1161/CIRCIMAGING.109.896654103 Liu T, Song D1, Dong J, et al. / Current Understanding of the Pathophysiology ofMyocardial Fibrosis and Its Quantitative Assessment in Heart Failure // FrontPhysiol. 2017 Apr 24;8:238. doi: 10.3389/fphys.2017.00238104 Liu Y, Cox SR, Morita T, Kourembanas S. / Hypoxia regulates vascular endothelialgrowth factor gene expression in endothelial cells. Identification of a 5’ enhancer //Circ Res.
1995 Sep;77(3):638-43.105 London GM, Guerin AP. / Influence of arterial pulse and reflected waves on bloodpressure and cardiac function // Am Heart J. 1999 Sep;138(3 Pt 2):220-4.106 Lu J, Wang X, Wang W, et al. / LOX-1 abrogation reduces cardiac hypertrophy andcollagen accumulation following chronic ischemia in the mouse // Gene Ther. 2012May;19(5):522-31. doi: 10.1038/gt.2011.133107 Maanja M, Wieslander B, Schlegel TT, et al. / Diffuse Myocardial FibrosisReduces Electrocardiographic Voltage Measures of Left Ventricular Hypertrophy129Independent of Left Ventricular Mass // J Am Heart Assoc. 2017 Jan 22;6(1). pii:e003795.
doi: 10.1161/JAHA.116.003795108 Maffi P, Secchi A. / The Burden of Diabetes: Emerging Data // Dev Ophthalmol.2017;60:1-5. doi: 10.1159/000459641109 Mandavia CH, Aroor AR, Demarco VG, Sowers JR. / Molecular and MetabolicMechanisms of Cardiac Dysfunction in Diabetes // Life Sci. 2013 Mar28;92(11):601-8. doi: 10.1016/j.lfs.2012.10.028110 Mbanya JC, Motala AA, Sobngwi E, Assah FK, Enoru ST. / Diabetes in subSaharan Africa // Lancet. 2010 Jun 26;375(9733):2254-66.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
